Overview
The Pharmaceutical Packaging Market is projected to be valued at USD 192.93 billion by 2027, with a 9.21% CAGR during the forecast period.
The report coverssegmentation and drivers for a better glimpse of the market in the coming years.The pharmaceutical packagingmarkethasregistered significant growth in adoption rates over the past few years due to rapid technological advancements in the pharmaceutical industry.
Request a Free Sample @ https://www.marketresearchfuture.com/sample_request/1291
Segmental Analysis
The growing demand for packaging from the pharmaceutical industry has been fueling the overall growth of the pharmaceutical packaging market. The pharmaceutical packaging market has been classified on the basis of type, packaging type, material, application, and region.
By type, the pharmaceutical packaging market has been segmented into rigid, semi-rigid, and flexible. The rigid segment is expected to grow at the fastest rate during the forecast period.
By packaging type, the pharmaceutical packaging market has been segmented into primary packaging and secondary packaging. The primary packaging segment is expected to grow at a faster rate during the forecast period.
Based on material, the pharmaceutical packaging market has been segmented into plastic, paper & paperboard, and glass. The paper & paperboard segment is likely to grow at the fastest rate during the forecast period.
Based on application, the global pharmaceutical packaging market has been segmented into generic drugs, branded drugs, medical tools & equipment, test kits, and nutraceuticals. The test kits segment is expected to grow at the fastest rate during the forecast period.
Competitive Analysis
The global pharmaceutical packaging market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players continually competing to gain a larger market share. High competition and rapid advancements in technology are some of the critical factors that could restrain the market growth. The vendors compete based on cost, product quality, reliability, and aftermarket services. Vendors must provide cost-effective and efficient products to survive and succeed in a competitive market environment.
The growth of the vendors is dependent on market conditions, government support, and industrial development. Thus, the vendors should focus on expanding their presence and improving their services. West pharmaceutical services Inc. (US), Gerresheimer (Germany), Schott AG(Germany), CCL Industries Inc. (Canada), Amcor Plc (Switzerland), AptarGroup Inc (US), and Berry Global (US)are some of the key players operating in the global market. These companies compete in terms of availability, quality, price, and technology. They consider acquisition as a key strategy in the global pharmaceutical packaging market. Although the international players dominate the market, regional and local players with small market shares also have a significant presence. The international players may strengthen their global market presence by heavily investing in product development during the forecast period.
Regional Analysis
Geographic analysis of the pharmaceutical packagings marketspans across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
The North American pharmaceutical packaging market is predicted to witness robust growth during the forecast period. The growth can be attributed to the global market players that are expanding their presence in the region, along with strategic developments between the raw material suppliers. For instance, in 2018, Hoffmann Neopac AG, the Switzerland-based manufacturer of primary packaging for the pharmaceutical and cosmetics industries, established a new manufacturing facility in the US. Moreover, Bormioli Pharma S.p.A., the Italian glass and plastic packaging company catering to the global pharmaceutical market, strengthened its services operations in North America. With this expansion, the company introduced its glass packaging solutions to North American pharmaceutical companies with designated sales support to nourish its long-term expertise in injectable pharmaceutical packaging.
In the US, the pharmaceutical packaging industry is witnessing rapid growth. With the expanding market for drugs, the demand for packaging increases continuously in the pharmaceutical industry. In October 2019, Gerresheimer AG (Germany) opened the glass innovation and technology center in New Jersey, the US, for offering primary packaging glass products in the pharmaceutical sector. This is expected to boost the growth of the pharmaceutical packaging market in the country.
Europe is projected to witness significant growth during the study period owing to the new directives set by the European Union (EU) authorities for pharmaceutical packaging on false medicines in 2017.The regional packaging players are implementing innovative methods to enhance their existing portfolio.
In 2017, the pharmaceutical packaging market in Asia-Pacific experienced strong growth, registering a CAGR of 8.22%. Stringent regulations by the governments of different countries, such as China, Japan, and South Korea, for plastic, glass, and paperboard packaging used in pharmaceutical companies create new opportunities for the global market players.
The pharmaceutical packaging market in the Middle East & Africa is projected to grow at a notable pace, mainly due to the increased per capita disposable income among individuals, growing healthcare awareness, and rising consumption of medicines and drugs.
In South America, the pharmaceutical industry is growing at a decent pace, mainly due to an increasing number of people diagnosed with various diseases. Moreover, the consumption of medicinal drugs and the growing demand for medical and healthcare centers are increasing considerably. Brazil, Argentina, Chile, and Colombia are thelargest contributors to the region’s market share.
Access Report Details @ https://www.marketresearchfuture.com/reports/pharmaceutical-packaging-market-1291
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune 411028
Maharashtra, India
+1 646 845 9312
Email:[email protected]
According to Market Research Future (MRFR), the global Pharmaceutical Glass Packaging Market is expected to grow at a 6% CAGR from 2017 to 2023 (forecast period).
The study offers a precise understanding of the global situation, the economic situation, and the COVID-19 analysis of the overall industry.Request a Free Sample @ https://www.marketresearchfuture.com/sample_request/5179Packaging relates to the process of providing protection, presentation, identification, the convenience of information, and compliance for a product during storage, transport, and display.
It helps to minimize the time needed for packaging pharmaceutical products, which helps increase the production and innovation of drug delivery systems and personalized drugs.
Glass packaging is primarily used in pharmaceutical packaging for liquid preparations due to their rigidity and superior protective properties.
The pharmaceutical glass packaging market research report presents company profiles of major companies active in the pharmaceutical glass packaging market globally.
In addition, increased awareness of the advantages of using glass packaging for pharmaceutical products and enhanced healthcare facilities drive the North American market for pharmaceutical glass packaging.
The global Specialty Pharmaceutical market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027.
This report also studies the global Specialty Pharmaceutical market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Read More: https://www.eternityinsights.com/report/specialty-pharmaceutical-marketThe following manufacturers are covered in this report, with sales, revenue, market share for each company:PfizerRocheAmgenAbbVieNovo NordiskJohnson & JohnsonSanofi-AventisMerckEli LillyNovartis3sbioChangchun High TechCP Guojian PharmacyBiotech PharmaGelgen BiopharmaInnoventMarket size by ProductAntibodyHormoneGrowth FactorsOtherMarket size by End UserTumorDiabetesCardiovascularHemophiliaOtherRequest Free Sample: https://www.eternityinsights.com/request-a-sample/34322Market size by RegionNorth AmericaUnited StatesCanadaMexicoAsia-PacificChinaIndiaJapanSouth KoreaAustraliaIndonesiaSingaporeMalaysiaPhilippinesThailandVietnamEuropeGermanyFranceUKItalySpainRussiaCentral & South AmericaBrazilRest of Central & South AmericaMiddle East & AfricaGCC CountriesTurkeyEgyptSouth AfricaInquiry Before Buy: https://www.eternityinsights.com/enquiry-before-buying/34332 The study objectives of this report are:To study and analyze the global Kidney (Renal) Fibrosis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.To understand the structure of Kidney (Renal) Fibrosis market by identifying its various subsegments.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).Focuses on the key global Kidney (Renal) Fibrosis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.To project the value and sales volume of Kidney (Renal) Fibrosis submarkets, with respect to key regions.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.In this study, the years considered to estimate the market size of Kidney (Renal) Fibrosis are as follows:History Year: 2017-2020Base Year: 2020Estimated Year: 2020Forecast Year 2021 to 2027This report includes the estimation of market size for value (million US$) and volume (K Units).
Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research.
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.For the data information by region, company, type and application, 2020 is considered as the base year.
Whenever data information was unavailable for the base year, the prior year has been considered.Similar Reports at:Menomune-A/C/Y/W-135 Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players and Applications Report 2021-2027Varicella Virus Vaccine Live Market Size, Share, Trends & Analysis By Type, Regional Outlook, Industry Insights, Key Players and Applications Report 2021-2027About Us:Our reputed “market research & consulting” portal, “Eternity Insights” publishes industry/market reports, equity & financial data, and analytical research reports.
ReportCrux Market Research has published a new report titled “Active Pharmaceutical Ingredients Market by API Type (Chemical API, and Biological API); by Drug Type (Innovative Drugs, Generic Prescription, and Over-the-Counter (OTC) Drugs); by Manufacturer (Captive (In-House) Manufacturer, and Merchant (Contract) Manufacturer); by Application (Anti-Diabetic Drugs, Non-Steroidal Anti-Inflammatory Drugs, Cardiovascular Drugs, Musculoskeletal Drugs, Neurology Drugs, Oncology Drugs, and Others); and by Region: Global Industry Trends, Dynamics, Competitive Insights and Forecast Analysis, 2020 – 2027”.Active Pharmaceutical Ingredients Market SizeActive Pharmaceutical Ingredients Market is estimated to grow from USD 173.7 Billion in 2019 to USD 285.3 Billion by 2027, at a CAGR of 6.4% during 2020-2027Market OverviewHealthcare investment has increased over time with improvements in the healthcare system.
This increasing focus on spending on health care positively is influencing the active pharmaceutical ingredients market.
Backed by factors such consistent pricing, availability of sufficient production units, and higher purchasing capacity, developed nations are projected to show faster growth in purchasing relative to emerging economies.Moreover, outsourcing of R activities has emerged as a major industry phenomenon because of reduced production costs and improved value chain operational performance.
To maintain a balanced product range, market participants depend on the possession of both branded and unbranded generic drugs.Growing prevalence of heart disease is also serving as a catalyst of growth for the overall market.
Epidemiological studies have shown how trends in behaviors such as dietary abnormalities and smoking that may lead to obesity are correlated with increased risk of disease.
APIs target cancer cells effectively and thereby reduce drug access to healthy tissues.The patent expirations of blockbuster drugs have given rise to generic copies wherein manufacturers have to bear the cost.
